Main > ONCOLOGY (**) > Leukemia>Myeloid>Acute>FLT3+ *** > Treatment > JP. A. Gilteritinib> > Companion Diagnostics>

---

Companion Diagnostics>'s subsections
>(*) EU Approval Date: 2019. 12.05.
>(*) JP Approval Date: 2019. 06.19.
>CDx FLT3 Mutation Assay
>Company
>Patent>Assignee; Claims; No.; Etc.
>Patent>Total USA No.: 2
>Patent>UpDate: 2019. 12.17.
>TradeMark
>TradeMark Web-Site

Companion Diagnostics>'s products
This section has no products